The release of wastewater contaminants in the Arctic

a case study from Cambridge Bay, Nunavut, Canada

Luis G. Chaves-Barquero, Kim Hoang Luong, C.J. Mundy, Charles W. Knapp, Mark L Hanson, Charles S. Wong

Research output: Contribution to journalArticle

9 Citations (Scopus)
27 Downloads (Pure)

Abstract

The treatment of municipal wastewater in the Arctic is challenging due to a variety of financial, operational, climatic and technical issues. To better understand the efficacy of current wastewater treatment in this region and the hazard posed to receiving waters, we assessed the occurrence of contaminants (i.e., pharmaceuticals, antibiotic resistance genes and nutrients) as they moved through a lagoon-based treatment system in Cambridge Bay in Nunavut, Canada. Wastewater treatment in this community is performed by the use of a lagoon-tundra wetland system that is discharged into the marine environment and is representative of current common practices throughout the region. In 2014, samples were collected before and during lagoon discharge from two locations in the main lagoon, one location downstream from the lagoon effluent and three locations offshore. Grab samples were collected to measure nutrients (e.g. total nitrogen and phosphorus) and the presence of antibiotic resistance gene-bearing microbes, and Polar Organic Chemical Integrative Samplers (POCIS) were deployed to collect passively organic contaminants in all locations. A total of six pharmaceuticals were detected from a screen of twenty-eight analytes during the study: atenolol, carbamazepine, clarithromycin, metoprolol, sulfamethoxazole and trimethoprim. The greatest concentrations of nutrients, antibiotic resistance genes (ARGs) and pharmaceuticals were found in sampling locations within the treatment lagoon. Offshore of the release point, we observed limited to no detection of pharmaceuticals and ARGs and no change in total nitrogen and phosphorus from pre-release. We conclude that the current concentrations of monitored pharmaceuticals do not pose a significant hazard at this time to aquatic organisms in Cambridge Bay.
Original languageEnglish
Pages (from-to)542-550
Number of pages9
JournalEnvironmental Pollution
Volume218
Early online date26 Jul 2016
DOIs
Publication statusPublished - 1 Nov 2016

Fingerprint

Nunavut
Waste Water
Drug products
Canada
Antibiotics
lagoon
Microbial Drug Resistance
Wastewater
antibiotic resistance
Impurities
drug
wastewater
Genes
Sewage lagoons
pollutant
Nutrients
Anti-Bacterial Agents
Pharmaceutical Preparations
gene
Food

Keywords

  • Arctic
  • pharmaceuticals
  • wastewater lagoons
  • risk assessment
  • nutrients
  • antibiotic resistance genes

Cite this

Chaves-Barquero, Luis G. ; Luong, Kim Hoang ; Mundy, C.J. ; Knapp, Charles W. ; Hanson, Mark L ; Wong, Charles S. / The release of wastewater contaminants in the Arctic : a case study from Cambridge Bay, Nunavut, Canada. In: Environmental Pollution. 2016 ; Vol. 218. pp. 542-550.
@article{625f0cc6fc5548d9a5a393189f007beb,
title = "The release of wastewater contaminants in the Arctic: a case study from Cambridge Bay, Nunavut, Canada",
abstract = "The treatment of municipal wastewater in the Arctic is challenging due to a variety of financial, operational, climatic and technical issues. To better understand the efficacy of current wastewater treatment in this region and the hazard posed to receiving waters, we assessed the occurrence of contaminants (i.e., pharmaceuticals, antibiotic resistance genes and nutrients) as they moved through a lagoon-based treatment system in Cambridge Bay in Nunavut, Canada. Wastewater treatment in this community is performed by the use of a lagoon-tundra wetland system that is discharged into the marine environment and is representative of current common practices throughout the region. In 2014, samples were collected before and during lagoon discharge from two locations in the main lagoon, one location downstream from the lagoon effluent and three locations offshore. Grab samples were collected to measure nutrients (e.g. total nitrogen and phosphorus) and the presence of antibiotic resistance gene-bearing microbes, and Polar Organic Chemical Integrative Samplers (POCIS) were deployed to collect passively organic contaminants in all locations. A total of six pharmaceuticals were detected from a screen of twenty-eight analytes during the study: atenolol, carbamazepine, clarithromycin, metoprolol, sulfamethoxazole and trimethoprim. The greatest concentrations of nutrients, antibiotic resistance genes (ARGs) and pharmaceuticals were found in sampling locations within the treatment lagoon. Offshore of the release point, we observed limited to no detection of pharmaceuticals and ARGs and no change in total nitrogen and phosphorus from pre-release. We conclude that the current concentrations of monitored pharmaceuticals do not pose a significant hazard at this time to aquatic organisms in Cambridge Bay.",
keywords = "Arctic, pharmaceuticals, wastewater lagoons, risk assessment, nutrients, antibiotic resistance genes",
author = "Chaves-Barquero, {Luis G.} and Luong, {Kim Hoang} and C.J. Mundy and Knapp, {Charles W.} and Hanson, {Mark L} and Wong, {Charles S.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.envpol.2016.07.036",
language = "English",
volume = "218",
pages = "542--550",
journal = "Environmental Pollution",
issn = "0269-7491",

}

The release of wastewater contaminants in the Arctic : a case study from Cambridge Bay, Nunavut, Canada. / Chaves-Barquero, Luis G.; Luong, Kim Hoang; Mundy, C.J.; Knapp, Charles W.; Hanson, Mark L; Wong, Charles S.

In: Environmental Pollution, Vol. 218, 01.11.2016, p. 542-550.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The release of wastewater contaminants in the Arctic

T2 - a case study from Cambridge Bay, Nunavut, Canada

AU - Chaves-Barquero, Luis G.

AU - Luong, Kim Hoang

AU - Mundy, C.J.

AU - Knapp, Charles W.

AU - Hanson, Mark L

AU - Wong, Charles S.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - The treatment of municipal wastewater in the Arctic is challenging due to a variety of financial, operational, climatic and technical issues. To better understand the efficacy of current wastewater treatment in this region and the hazard posed to receiving waters, we assessed the occurrence of contaminants (i.e., pharmaceuticals, antibiotic resistance genes and nutrients) as they moved through a lagoon-based treatment system in Cambridge Bay in Nunavut, Canada. Wastewater treatment in this community is performed by the use of a lagoon-tundra wetland system that is discharged into the marine environment and is representative of current common practices throughout the region. In 2014, samples were collected before and during lagoon discharge from two locations in the main lagoon, one location downstream from the lagoon effluent and three locations offshore. Grab samples were collected to measure nutrients (e.g. total nitrogen and phosphorus) and the presence of antibiotic resistance gene-bearing microbes, and Polar Organic Chemical Integrative Samplers (POCIS) were deployed to collect passively organic contaminants in all locations. A total of six pharmaceuticals were detected from a screen of twenty-eight analytes during the study: atenolol, carbamazepine, clarithromycin, metoprolol, sulfamethoxazole and trimethoprim. The greatest concentrations of nutrients, antibiotic resistance genes (ARGs) and pharmaceuticals were found in sampling locations within the treatment lagoon. Offshore of the release point, we observed limited to no detection of pharmaceuticals and ARGs and no change in total nitrogen and phosphorus from pre-release. We conclude that the current concentrations of monitored pharmaceuticals do not pose a significant hazard at this time to aquatic organisms in Cambridge Bay.

AB - The treatment of municipal wastewater in the Arctic is challenging due to a variety of financial, operational, climatic and technical issues. To better understand the efficacy of current wastewater treatment in this region and the hazard posed to receiving waters, we assessed the occurrence of contaminants (i.e., pharmaceuticals, antibiotic resistance genes and nutrients) as they moved through a lagoon-based treatment system in Cambridge Bay in Nunavut, Canada. Wastewater treatment in this community is performed by the use of a lagoon-tundra wetland system that is discharged into the marine environment and is representative of current common practices throughout the region. In 2014, samples were collected before and during lagoon discharge from two locations in the main lagoon, one location downstream from the lagoon effluent and three locations offshore. Grab samples were collected to measure nutrients (e.g. total nitrogen and phosphorus) and the presence of antibiotic resistance gene-bearing microbes, and Polar Organic Chemical Integrative Samplers (POCIS) were deployed to collect passively organic contaminants in all locations. A total of six pharmaceuticals were detected from a screen of twenty-eight analytes during the study: atenolol, carbamazepine, clarithromycin, metoprolol, sulfamethoxazole and trimethoprim. The greatest concentrations of nutrients, antibiotic resistance genes (ARGs) and pharmaceuticals were found in sampling locations within the treatment lagoon. Offshore of the release point, we observed limited to no detection of pharmaceuticals and ARGs and no change in total nitrogen and phosphorus from pre-release. We conclude that the current concentrations of monitored pharmaceuticals do not pose a significant hazard at this time to aquatic organisms in Cambridge Bay.

KW - Arctic

KW - pharmaceuticals

KW - wastewater lagoons

KW - risk assessment

KW - nutrients

KW - antibiotic resistance genes

UR - http://www.sciencedirect.com/science/journal/02697491

UR - http://www.sciencedirect.com/science/article/pii/S0269749116306108

U2 - 10.1016/j.envpol.2016.07.036

DO - 10.1016/j.envpol.2016.07.036

M3 - Article

VL - 218

SP - 542

EP - 550

JO - Environmental Pollution

JF - Environmental Pollution

SN - 0269-7491

ER -